M4MM
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Operators sharpened their focus on balance sheets and strategic footholds while policymakers grappled with regulatory gaps and emerging threats. Funding flowed into psychedelics innovation, MSOs reported Q3 2025 earnings, trimmed underperformers, and ...
Cronos Group Reports Q3 2025 Financial Results
TORONTO – Cronos Group Inc., a Canadian Cannabis producer with a growing international footprint, reported third-quarter results that marked new highs for revenue, profitability, and cash reserves, even as domestic challenges in Canada tempered some ...
Aurora Cannabis Reports Q2 FY2026 Financial Results
EDMONTON – Aurora Cannabis Inc. posted a solid second quarter for its fiscal 2026, with total net revenue climbing 11% to CA$90.4 million, driven by a surge in international medical Cannabis sales that highlighted the ...
Switzerland Advances Draft for Regulated Cannabis Sales with Centralized Online Distribution
BERN – Switzerland has released a draft proposal for legalizing adult-use Cannabis, featuring a tightly controlled system that includes one authorized online retailer alongside licensed brick-and-mortar stores. The plan, now open for public input through ...
GTI Opens Rise Dispensaries in Minnesota, Expanding Access to Adult-Use Cannabis Buyers
CHICAGO – Green Thumb Industries (GTI) announced opening its Rise dispensaries across Minnesota, marking a key step in the state's shift to broader access for adult consumers. The move comes two years after lawmakers approved ...
California Reaps $259.7M in Cannabis Tax Revenue for Q2 2025
LOS ANGELES – California's legal Cannabis sector delivered $259.7 million in tax revenue during the second quarter of 2025, based on data released by the California Department of Tax and Fee Administration (CDTFA). The figure ...
Verano Adds Crystal River Location, Reaching 82 Dispensaries in Florida
CHICAGO – Verano Holdings Corp. has expanded its presence in Florida by opening a new MÜV dispensary in Crystal River, bringing its total to 82 stores statewide and 152 nationwide. This move bolsters Verano's network ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Operators sharpened their focus on balance sheets and strategic footholds while policymakers grappled with regulatory gaps and emerging threats. Funding flowed into psychedelics innovation, MSOs reported Q3 2025 earnings, trimmed underperformers, and ...
Cronos Group Reports Q3 2025 Financial Results
TORONTO – Cronos Group Inc., a Canadian Cannabis producer with a growing international footprint, reported third-quarter results that marked new highs for revenue, profitability, and cash reserves, even as domestic challenges in Canada tempered some ...
Aurora Cannabis Reports Q2 FY2026 Financial Results
EDMONTON – Aurora Cannabis Inc. posted a solid second quarter for its fiscal 2026, with total net revenue climbing 11% to CA$90.4 million, driven by a surge in international medical Cannabis sales that highlighted the ...
Georgia Implements New Age Restrictions and Regulations on Hemp-Derived Products
NEW YORK- In a recent legislative development, Georgia is poised to enforce a new law restricting the sale of hemp-derived cannabinoid products, including CBD and intoxicating substances like delta-8 THC and delta-9 THC, to individuals ...
Awakn Life Sciences Expands into U.S. with Oklahoma Licensing Agreement
LOS ANGELES- Awakn Life Sciences Corp., a biotechnology company specializing in the development of medication-assisted treatments for addiction, particularly focusing on Alcohol Use Disorder (AUD), announced a significant expansion of its operations into the United ...
Ontario Anticipates Record Cannabis Revenue
LOS ANGELES- In a landmark financial forecast, Ontario expects to garner over CA$379 million from its share of the federal cannabis duty for the fiscal year April 2024 to March 2025, marking a significant 22.2% ...
University of Calgary Studies Psychedelic Treatment for Alcohol Use Disorder
LOS ANGELES- The University of Calgary, through its Hotchkiss Brain Institute, has embarked on a study to examine the potential of psychedelics, specifically psilocybin, in treating Alcohol Use Disorder (AUD). With plans to recruit 128 ...
Delaware Expands Medical Cannabis Program Access
NEW YORK- Delaware lawmakers have passed a significant bill aimed at broadening access to the state's medical cannabis program. On Thursday, the Delaware Senate approved a proposal that grants healthcare providers the discretion to certify ...
Imperial Brands Acquires Stake in Auxly Cannabis Group
LOS ANGELES- Imperial Brands has effectively become the largest shareholder of Auxly Cannabis Group, acquiring a 19.8% stake after converting over 123.4 million Canadian dollars ($90.6 million) in total debt into shares. This move was ...
North Carolina Senate Approves Medical Cannabis Legalization Bill
LOS ANGELES- The North Carolina Senate gave final approval to a medical cannabis legalization bill this week, sending the proposal to the House for consideration. Notably, the proposal would not legalize adult-use cannabis even under ...
Maryland Awards Social Equity Cannabis Licenses
LOS ANGELES- In a significant move by the Maryland Cannabis Administration, 174 social equity cannabis licenses were awarded through a lottery system, showcasing the state's commitment to diversity and inclusion within the burgeoning cannabis industry. ...
Florida Supreme Court to Decide Fate of Cannabis Legalization
LOS ANGELES- The Florida Supreme Court is set to make a pivotal decision regarding the appearance of an adult-use cannabis legalization amendment on the November ballot, according to ClickOrlando. This determination follows a challenge by ...
Organigram Announces Investment in Open Book Extracts
NEW YORK- Organigram Holdings, a Canadian cannabis company, announced a $2 million investment in North Carolina-based Open Book Extracts. This move signifies Organigram's entry into the U.S. cannabis market, facilitated by an investment from British ...
Algernon Pharmaceuticals Advances Research Program
LOS ANGELES – In a significant move that underscores its commitment to innovative medical research, Algernon Pharmaceuticals Inc. announced its decision to prioritize its AP-188 ("N,N-Dimethyltryptamine" or "DMT") stroke research program. This announcement follows the ...
Germany Ushers in a New Era with Adult-Use Cannabis Legalization
BERLIN- As the clock struck midnight in Germany, transitioning from March 31st to April 1st, the nation embraced a historic shift in its drug policy landscape. Germany’s new adult-use cannabis legalization law, known as the ...
Colombia’s Medical Cannabis Exports Surge to $10.8 Million Amid Regulatory Enhancements
BOGOTA- In a notable advancement for Colombia's burgeoning medical cannabis industry, exports have seen a significant rise, reaching $10.8 million in 2023, as reported by ProColombia, a key government agency dedicated to fostering nontraditional Colombian ...
Glass House Brands Report Revenue and Profits
LOS ANGELES- In a notable financial turnaround, Glass House Brands, a California-based cannabis producer and retailer, reported significant growth in its fourth-quarter earnings, leading to a record revenue of $160.8 million for the fiscal year ...
ICER Raises Concerns Over MDMA-Assisted Psychotherapy for PTSD
LOS ANGELES- The Institute for Clinical and Economic Review (ICER) has recently highlighted significant concerns regarding the clinical evidence behind MDMA-assisted psychotherapy (MDMA-AP) for post-traumatic stress disorder (PTSD), according to a draft evidence report. This ...
